AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade

Nature Cell Biology

Volumn 12, Issue 12, 2010, Pages 1242-1249

  Smith, F Donelson ^a   Langeberg, Lorene K ^a   Cellurale, Cristina ^b   Pawson, Tony ^c   Morrison, Deborah K ^d   Davis, Roger J ^b   Scott, John D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Laboratory of Cell and Developmental Signalling   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KSR 1; PROTEIN LBC; RAF PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN 3T3; CELL STRAIN HEK293; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FIBROBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

A KINASE ANCHOR PROTEINS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; SEQUENCE ALIGNMENT;

EID: 78649832811     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb2130     Document Type: Article

References (27)

1. Raman, M., Chen, W. & Cobb, M. H. Differential regulation and properties of MAPKs. Oncogene 26, 3100-3112 (2007).
2. Mansour, S. J. et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966-970 (1994).
3. Wan, P. T. et al. Mechanism of activation of the RAF-ERK signaling pathway by onco- genic mutations of B-RAF. Cell 116, 855-867 (2004).
4. Wilhelm, S. M. et al. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol. Cancer Ther. 7, 3129-3140 (2008).
5. Tsai, J. et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc. Natl Acad. Sci. USA 105, 3041-3046 (2008).
6. Wu, J. et al. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3', 5'-monophosphate. Science 262, 1065-1072 (1993).
7. Cook, S. J. & McCormick, F. Inhibition by cAMP of ras-dependent activation of raf. Science 262, 1069-1072 (1993).
8. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22 (2003).
9. Stork, P. J. & Schmitt, J. M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258-266 (2002).
10. Bos, J. L. Epac: a new cAMP target and new avenues in cAMP research. Nat. Rev. Mol. Cell Biol. 4, 733-738 (2003).
11. Dumaz, N. & Marais, R. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. FEBS J. 272, 3491-3504 (2005).
12. Dodge-Kafka, K. L. et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437, 574-578 (2005).
13. Diviani, D., Soderling, J. & Scott, J. D. AKAP-Lbc anchors protein kinase A and nucle- ates Gα12-selective Rho-mediated stress fiber formation. J. Biol. Chem. 276, 44247-44257 (2001).
14. Carnegie, G. K., Smith, F. D., McConnachie, G., Langeberg, L. K. & Scott, J. D. AKAP- Lbc nucleates a protein kinase D activation scaffold. Mol. Cell 15, 889-899 (2004).
15. Therrien, M., Michaud, N. R., Rubin, G. M. & Morrison, D. K. KSR modulates signal propagation within the MAPK cascade. Genes Dev. 10, 2684-2695 (1996).
16. Harvey, C. D. et al. A genetically encoded fluorescent sensor of ERK activity. Proc. Natl Acad. Sci. USA 105, 19264-19269 (2008).
17. Leevers, S. J., Paterson, H. F. & Marshall, C. J. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369, 411-414 (1994).
18. Muller, J., Ory, S., Copeland, T., Piwnica-Worms, H. & Morrison, D. K. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol. Cell 8, 983-993 (2001).
19. Scott, J. D. & Pawson, T. Cell signaling in space and time: where proteins come together and when they're apart. Science 326, 1220-1224 (2009).
20. Morrison, D. K. & Davis, R. J. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19, 91-118 (2003).
21. Bhattacharyya, R. P., Remenyi, A., Yeh, B. J. & Lim, W. A. Domains, motifs and scaf- folds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu. Rev. Biochem. 75, 655-680 (2006).
22. Matheny, S. A. et al. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 427, 256-260 (2004).
23. Smith, F. D., Langeberg, L. K. & Scott, J. D. The where's and when's of kinase anchor- ing. Trends Biochem. Sci. 31, 316-323 (2006).
24. Nguyen, A. et al. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol. Cell Biol. 22, 3035-3045 (2002).
25. Dumaz, N. & Marais, R. Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J. Biol. Chem. 278, 29819-29823 (2003).
26. Dhillon, A. S. et al. Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol. Cell Biol. 22, 3237-3246 (2002).
27. Jin, J. et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr. Biol. 14, 1436-1450 (2004).